EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe

Ana-Maria Filip iD, Sabrina-Nicoleta Munteanu iD, Simona Mocan, Patrick-Lazăr-Dominik Chiciudean, Luciana Arjoca iD, Cristina Monica Pantea iD, Marian-Ioan Filip iD, Anca Negovan

Medical Sciences · 2026

DOI: 10.3390/medsci14060661 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medical Sciences, 2026. Verfasst von Ana-Maria Filip und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Emergency County Hospital of Targu Mures, 540136 Targu Mures, Romania. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Precancerous Conditions, Gastritis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune gastritis (AIG) and Helicobacter pylori gastritis are distinct etiologies of chronic gastritis, yet comparative data on their long-term progression remain limited.

Objectives

We compared the evolution of precancerous gastric lesions in patients with AIG and H. pylori-associated gastritis.

Methods

This retrospective single-center cohort included 116 patients (52 histologically defined AIG, 64 H. pylori-associated gastritis) who underwent two upper endoscopies with Sydney-protocol biopsies at least 12 months apart between 2013 and 2024 (median follow-up 60 and 49 months). The primary outcome was the development of glandular atrophy or intestinal metaplasia (IM) not present at baseline.

Results

New atrophy or IM developed in 61.5% (32/52) of AIG and 34.4% (22/64) of H. pylori patients (adjusted odds ratio [OR] 3.81, 95% confidence interval [CI] 1.53–9.49). Incident atrophy was more frequent in AIG (65.1% vs. 31.5%), including in comparison with baseline H. pylori-positive patients only (adjusted OR 3.02, 95% CI 1.08–8.46), whereas differences in IM were less consistent. Progression occurred in 42.9% of patients who were H. pylori-negative after treatment and 55.6% of persistently infected patients (p = 0.70). Proton pump inhibitor (PPI) use, an exploratory clinical risk score, and symptom changes were not associated with progression.

Conclusions

In this selected cohort with repeat endoscopy, histologically defined AIG was associated with more frequent histological progression, particularly glandular atrophy, than H. pylori-associated gastritis. Prospective studies with serologically confirmed AIG and neoplastic endpoints are needed to inform risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsPrecancerous ConditionsGastritisAutoimmune DiseasesStomach NeoplasmsHumansFemaleMaleDisease ProgressionMiddle AgedRetrospective StudiesLongitudinal StudiesMetaplasiaAdultAgedAtrophy

Stichwörter der Autor:innen

Helicobacter pyloriautoimmune gastritisdisease progressionintestinal metaplasiaprecancerous conditions

Autor:innen und Institutionen

  • Department of Internal Medicine I, Emergency County Hospital of Targu Mures, 540136 Targu Mures, Romania.
  • Department of Clinical Science-Internal Medicine, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540139 Targu Mures, Romania.
  • Pathology Department, Emergency County Hospital of Targu Mures, 540136 Targu Mures, Romania.
  • Oncology Department, County Clinical Hospital of Targu Mures, 540140 Targu Mures, Romania.
  • Faculty of Medicine, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540139 Targu Mures, Romania.
  • Gastroenterology Department, Emergency County Hospital of Targu Mures, 540136 Targu Mures, Romania.

ORCID-Profile: Ana-Maria Filip, Sabrina-Nicoleta Munteanu, Luciana Arjoca, Cristina Monica Pantea, Marian-Ioan Filip

Zitieren

APA

Filip, A. M., Munteanu, S. N., Mocan, S., Chiciudean, P. L., Arjoca, L., Pantea, C. M., Filip, M. I., & Negovan, A. (2026). Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe. Medical Sciences. https://doi.org/10.3390/medsci14060661

Vancouver

Filip AM, Munteanu SN, Mocan S, Chiciudean PL, Arjoca L, Pantea CM, et al. Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe. Medical Sciences. 2026. doi:10.3390/medsci14060661

BibTeX
@article{Filip2026,
  author = {Filip, Ana-Maria and Munteanu, Sabrina-Nicoleta and Mocan, Simona and Chiciudean, Patrick-Lazăr-Dominik and Arjoca, Luciana and Pantea, Cristina Monica and Filip, Marian-Ioan and Negovan, Anca},
  title = {Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14060661}
}
Kostenlos starten →